International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice
Read More 6 minute read Pharma Industry News Is mutant-selective JAK2 inhibition ready for clinical reality after Prelude Therapeutics’ FDA IND clearance? Prelude Therapeutics gains FDA IND clearance for PRT12396. Read how mutant-selective JAK2 inhibition could reshape MPN drug development. bySoujanya RaviFebruary 6, 2026